-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INCB-57643 in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INCB-57643 in Myelodysplastic Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.INCB-57643 in Myelodysplastic Syndrome Drug Details:INCB-57643 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IOA-244 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IOA-244 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.IOA-244 in Non-Small Cell Lung Cancer Drug Details:IOA-244 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RiVax in Poisoning
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RiVax in Poisoning report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RiVax in PoisoningDrug Details:RiVax is under development to protect against exposure to ricin toxin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Hypericin Sodium in Mycosis Fungoides
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Hypericin Sodium in Mycosis Fungoides report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Hypericin Sodium in Mycosis FungoidesDrug Details:Hypericin (SGX-301, HBP-347) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PF-07328948 in Diastolic Heart Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PF-07328948 in Diastolic Heart Failure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PF-07328948 in Diastolic Heart FailureDrug Details: PF-07328948 is under development for the...
-
Company Profile
Soligenix Inc – Company Profile
Soligenix Inc (Soligenix) is a late-stage biopharmaceutical company which focuses on the development and commercialization of products for the treatment of rare diseases and unmet medical needs. It develops specialized biotherapeutics for the treatment of orphan diseases such as cutaneous T-cell lymphoma, pediatric Crohn's disease, oral mucositis, mild to moderate psoriasis, and acute radiation enteritis. It develops proprietary formulations of oral beclomethasone 17,21-dipropionate (BDP) for the treatment of gastrointestinal disorders that are characterized by high inflammation. The company has active...
Add to Basket -
Product Insights
Net Present Value Model: HyBryte
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model HyBryte Drug Details Hypericin (SGX-301, HBP-347)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – hypericin
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry hypericin Drug Details Hypericin (SGX-301, HBP-347) is under development for the treatment of mild-moderate...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – beclomethasone dipropionate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry beclomethasone dipropionate Drug Details SGX-203 (beclomethasone 17,21-dipropionate or BDP) is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – SGX-201
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SGX-201 Drug Details SGX-201 (delayed release beclomethasone 17,21-dipropionate) is under development for the prevention...